Abstract: To explore the effectiveness, safety and cost between urinary follicle stimulating hormone (uFSH) and recombinant follicle stimulating hormone (rFSH) in controlled ovarian stimulation (COS) in China. Data were collected from 16 reproductive centers in China covering oocytes collection time from May 1, 2015 to June 30, 2018. Eligible patients were over 18 years old, adopting COS with uFSH (uFSH group) or rFSH (rFSH group) as start gonadotropins (Gn), and using in vitro fertilization (IVF) and (or) intracytoplasmic sperm injection for fertilisation, excluding frozen embryo recovery cycle. Generalised estimating equation was used to address the violation of independency assumption between cycles due to multiple IVF cycles for one person and clustering nature of cycles carried out within one center. Controlling variables included age, body mass index, anti-Müllerian hormone level, cause of infertility, ovulation protocol, type of fertilisation, number of embryos transferred, number of days of Gn use. Totally 102 061 cycles met eligibility criteria and were included in the analyses. In terms of effectiveness, after controlling relevant unbalanced baseline characteristics, compared with rFSH group, the high oocyte retrieval (>15 oocytes was considered high retrieval) rate of uFSH group significantly decreased in gonadotropin-releasing hormone agonist protocol (=0.642, <0.01) and in gonadotropin-releasing hormone antagonist protocol (=0.556, =0.001), but the clinical pregnancy rate per transfer cycle and the live birth rate per transfer cycle significantly increased (=1.179, =1.169, both <0.01) in both agonist and antagonist protocols. For safety, multiple analysis result demonstrated that in the agonist protocol, compared with rFSH group, the incidence of moderate to severe ovarian hyperstimulation syndrome of uFSH group significantly decreased (=0.644, =0.002). The differences in ectopic pregnancy rate and multiple pregnancy rate between the uFSH and rFSH groups were not significant (=0.890, =0.470) in all patients. In terms of cost, compared with rFSH group, the uFSH group had lower total Gn costs for each patient (<0.01). For patients who underwent COS, uFSH has better safety, and economic profiles over rFSH in China.

CSRM guideline for the use of ovulation induction drug

International standard of Traditional Chinese Medicine techniques: clinical guidelines for dysmenorrhea (2022)

CSRM guideline for multifetal pregnancy reduction(2016)

[Effectiveness, safety and cost of urinary follicle stimulating hormone in controlled ovarian stimulation in China: multi-center retrospective cohort study of 102 061 in vitro fertilization cycles].

Interpretation to SOGC clinical practice guideline: No. 362-Ovulation Induction in Polycystic Ovary Syndrome

CSRM specifications for developing guideline consensus

Rational use of controlled ovarian stimulation

Guideline for Diagnosis and Treatment of Infertility in Advanced Age Women (revised Edition)

Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs.

A consensus of poor ovarian response

Diagnostic Guidelines for Infertility

A Chinese Practice Guideline of the Assisted Reproductive Technology Strategies for Women with Advanced Age

Effectiveness of GnRH Antagonist in the Management of Subfertile Couples Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: a Meta-Analysis.

Reevaluation on the role of clomiphene citrate during induction of ovulation

The Use of Recombinant FSH (Follitropin-β Solution) in Assisted Reproductive Techniques

The Application of Long-Acting and Short-Acting Forms of Gonadotrophin-Releasing Hormone Agonists in Long Protocol of IVF/ICSI Cycles

A randomized, single-blind, parallel-controlled and multicentre study：compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group Ⅱ anovulatory infertility

Improved reproductive outcomes in normogonadotropic oligomenorrheic women undergoing ovarian stimulation with intrauterine insemination: a retrospective cohort analysis of real-world data

Efficacy and safety of domestic produced recombinant human chorionic gonadotropin in Chinese women undergoing controlled ovarian hyperstimulation : a randomized controlled trial

Discussion of the Relative Factors about the Outcome of Ovulation and Pregnancy by Different Inducing Protocol and Fertilizing Style

A study about the effect of letrozole in ovulation induction in ovulatory infertile women-a comparison with clomiphene citrate